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Abstract
Background: Hepatitis E virus (HEV) transmitted via the oral route through the consumption of contaminated
water or uncooked or undercooked contaminated meat has been implicated in major outbreaks. Rats may play a
critical role in HEV outbreaks, considering their negative effects on environmental hygiene and food sanitation.
Although the serological evidence of HEV infection in wild rodents has been reported worldwide, the infectivity
and propagation of HEV in wild rats remain unknown. To investigate if rats are a possible carrier of HEV, we
studied wild Norway rats (Rattus norvegicus) that were caught near a pig farm, where HEV was prevalent among
the pigs.
Methods: We examined 56 Norway rats for HEV. RNA from internal organs was examined for RT-PCR and positive
samples were sequenced. Positive tissue samples were incubated with A549 cell line to isolate HEV. Anti-HEV
antibodies were detected by ELISA.
Results: Sixteen rats were seropositive, and the HEV RNA was detected in 10 of the 56 rats. Sequencing of the
partial ORF1 gene from 7 samples resulted in partially sequenced HEV, belonging to genotype 3, which was
genetically identical to the HEV prevalent in the swine from the source farm. The infectious HEVs were isolated
from the Norway rats by using the human A549 cell line.
Conclusions: There was a relatively high prevalence (17.9%) of the HEV genome in wild Norway rats. The virus was
mainly detected in the liver and spleen. The results indicate that these animals might be possible carrier of swine
HEV in endemic regions. The HEV contamination risk due to rats needs to be examined in human habitats.
Background
Hepatitis E virus (HEV) is a causative agent of viral
hepatitis transmitted via the oral route in humans. The
clinical symptoms of HEV infection vary from asympto-
matic to acute fulminant hepatitis. In humans, preg-
nancy and underlying liver diseases are considered risk
factors for severe cases of HEV [1,2] and high mortality
rates have been reported among pregnant women [3-6].
Also, chronic hepatitis associated with HEV was recently
reported in organ transplant recipients [7].
HEV is a non-enveloped single-stranded positive-sense
RNA virus classified as the sole member of the genus
Hepevirus in the family Hepeviridae [8]. The 7.2-kb gen-
ome of HEV is composed of 3 open reading frames
(ORFs): ORF1 (a non-structural protein), ORF2 (a cap-
sid protein), and ORF3 (accessory proteins associated
with virion cellular protein kinase activity and virion
release) [9-12].
HEVs associated with human hepatitis are classified
into 4 genotypes [13]. Genotypes 1 and 2 of HEVs cause
waterborne diseases, these genotypes are endemic in
developing countries and cause outbreaks involving
large populations [14,15]; meanwhile, genotypes 3 and 4
are generally considered zoonotic HEVs. Molecular ana-
lysis of the virus in patients and contaminated food pro-
vide evidence for direct food-borne transmission of the
virus [16-18]. Recently, HEVs were detected in rabbits
in China and rats in Germany; however, their infectivity
to humans remains undetermined [19,20].
Epidemiological studies suggest that pigs are an
important virus source of human HEV infections
[21-25]. Many studies have shown that HEV infection
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denced by the detection of the HEV RNA or HEV-speci-
fic antibodies [19,26-28]. Although the prevalence of
HEV-specific antibodies in wild rodents is well docu-
mented [28-31], there is only a single report of HEV iso-
lated from rats in Europe [20]. Besides natural infection,
a few cases of successful experimental infections of HEV
genotype 1 to Wistar rats [32], HEV genotype 3 to
Mongolian gerbils [33], and HEV genotype 4 to nude
mice [34] have been reported. Although the transmis-
sion of the virus from wild rodents to domestic animals
(e.g., pigs) is possible, the extent of this risk remains
unknown [35]. To investigate whether rodents can serve
as reservoirs of porcine HEV, we examined HEV infec-
tion in wild rats caught around a pig farm where HEV
infection was prevalent. To determine whether wild rats
are reservoirs of swine HEV, we performed viral genome
detection by reverse transcription-polymerase chain
reaction (RT-PCR), serological examination, and virus
isolation in wild rats.
Methods
Animals
Norway rats (Rattus norvegicus)w e r ec a u g h t ,u s i n g
commercial snap traps at 6 different locations, around a
pig farm where HEV genotype 3 was prevalent among
pigs (Hokkaido, Japan) [36]. The farm consists of three
buildings. The capture locations surrounded 3 different
buildings where the grow-finishing pigs (about 120 total
head counts) were reared. Our previous study revealed
that all the pigs were infected with HEV genotype 3.
These studies were performed in accordance with the
guidelines for the capture, handling, and care of mam-
mals of the Mammalogical Society of Japan. All animal
experiments were approved by the Rakuno Gakuen Uni-
versity Ethical Committee for Animal Experiment Regu-
lation, Hokkaido, Japan (approved #VH21C10).
The power analysis used to calculate the number of
animals required for the study was performed on the
basis of the 95% confidence interval shown on the Rao-
soft
® website (http://www.raosoft.com/samplesize.html).
Because the prevalence rate of HEV infection in wild
rodents was estimated to be approximately 10% [28-31],
the values required for calculating the sample size were
set as follows: infection rate, 10%; margin of error that
determines the range of the 95% confidence interval,
5%; and confidence level that refers to the likelihood of
95% confident interval, 90%. The power analysis indi-
c a t e dt h ea p p r o p r i a t es a m p l es i z et ob e9 7t oo b t a i n
10% HEV infection in rats with a 5% margin of error.
Since we found a sufficient number of HEV infections
in rats when 56 animals were examined, no further cap-
turing was performed.
Sampling and RNA extraction
The liver, spleen, intestines, and blood were collected
from 56 wild rats to determine the presence of HEV
RNA. Tissue and serum samples were collected from
each rat, and the samples were stored at -80°C until
analysis. Blood was collected from the hearts of dead
wild rats by using filter paper (Toyo Roshi; Advantec,
Tokyo, Japan) according to the manufacturer’s
instructions. The filter paper was dissolved in 1 mL
of phosphate-buffered saline (PBS) and subsequently
diluted (1:25) to make serum samples. During tissue
collection from wild rats, each dissection instrument
was sterilized to avoid contaminating tissues with
HEV RNA. Tissue samples (100 mg) were homoge-
nized using zirconia beads with a TissueLyser (Qia-
gen GmbH, Hilden, Germany). Viral RNA was
extracted from 100 mg of the tissue sample by using
1 mL of TRIzol reagent (Life Technologies Corp.,
Carlsbad, CA) according to the manufacturer’s
instructions. The final elution was carried out using
50 μLo fR N a s e - f r e eH 2O. The RNA extracted from
HEV-infected (genotype 3) swine livers was used as a
positive control.
ELISA
Anti-HEV antibodies were detected by ELISA with a
commercial kit (Viragent HEV-Ab kit; Cosmic Corpora-
t i o n ,T o k y o ,J a p a n )t h a tu s e dat r u n c a t e dr e c o m b i n a n t
HEV ORF2 protein expressed in silkworm pupae [37]
according to the manufacturer’s instructions. For the
positive control serum, 3 Wistar rats were subcuta-
neously immunized with ORF2 antigen (100 μg/rat) 3
times every 2 weeks. The recombinant ORF2 protein
was produced as a fusion protein with glutathione-S-
transferase (GST) from the plasmid, pGEX-AC2.1,
which encodes the ORF2 antigen (genotype 3). TALON
Metal Affinity Resin (Clontech Inc., Palo Alto, CA) was
used to purify the recombinant ORF2 protein. The sera
from 5 intact Wistar rats were used as negative controls.
The serum samples were diluted in buffer (1:100) and
were incubated for 1 h at room temperature. Because
the ELISA kit was developed for detecting human anti-
bodies, an HRP-conjugated anti-rat IgG antibody
(Zymed Inc., South San Francisco, CA) was used as the
secondary antibody. After the secondary antibody reac-
tions, 50 μLo fT M B( 3 , 3 ’,5,5’-tetramethylbenzidine)
(Kirkegaard & Perry Laboratories Inc., Baltimore, MD)
was added; after 30 min incubation at room tempera-
ture, 50 μL of 2 M sulfuric acid was added to stop the
reaction. The optical density at 450 nm (OD450)w a s
measured. The cutoff value for IgG ELISA was calcu-
lated as the mean OD + 3 SDs of 5 uninfected Wistar
rats (cutoff: OD 0.3).
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Initially, the HEV RNA of the 5’ terminal region of ORF1
was detected by semi-nested RT-PCR [36] with the sense
primer HE61 (5’-CACRTATGTGGTCGAYGCCATG-
GAG-3’; R = A or G, Y = C or T) and the antisense pri-
mer HE51 (5’-GCCKRACYACCACAGCATTCG-3’;K=
G or T) for reverse transcription (RT) and first round of
PCR and the internal sense primer HE50 (5’-
AAGGCTCCTGGCRTYACWAC-3’;W=Ao rT )f o r
the second round of PCR to confirm the first round of
PCR products. Reverse transcription and first-round
amplification were carried out using the OneStep RT-
PCR Kit (Qiagen). In each reaction, 5-μL aliquots of viral
RNA solution were used. The reactions were performed
in an Eppendorf Mastercycler (Eppendorf, Hamburg,
Germany) under the following conditions: RT at 50°C for
30 min, denaturation at 95°C for 15 min; 45 cycles of
denaturation at 95°C for 15 s each, annealing at 55°C for
30 s, and elongation at 72°C for 30 s; and final extension
at 72°C for 7 min. After the first round of PCR, 1-μL
PCR product was amplified under the following condi-
tions: 20 cycles of denaturation at 95°C for 15 s each,
annealing at 60°C for 30 s, and elongation at 72°C for 15
s, followed by a final incubation at 72°C for 7 min. The
amplified second-round PCR products were confirmed
by 2% gel electrophoresis. The expected amplicon sizes
of ORF1 were 125 bp and 85 bp in the first- and second-
round PCRs, respectively. The RT-PCR-positive samples
were also confirmed by semi-nested RT-PCR for the ORF
2 region by using the sense primer HE169 (5’-GAGGAG-
GAGGCTACTTCCG-3’) and the antisense primer HE
171 (5’-CAGCCGACGAAATCAATTCTGTCG-3’)f o r
the RT and first-round PCR, and for the semi-nested
PCR primer HE170 (5’-GTAATGCTTTGCATT-
CACGGCTCC-3’). The expected amplicon sizes of ORF2
for the first- and second-round PCRs were 373 bp and
349 bp, respectively. A 349-bp PCR amplicon was deter-
mined to be specific to HEV.
The PCR products from 7 positive samples (3 spleens
and 4 intestines from 6 rats captured at 6 different loca-
tions) were excised from the gel, purified using QIAquick
Gel Extraction Kit (Qiagen) and sequenced to confirm
the specificity of the RT-PCR reaction. The purified pro-
ducts were cloned into a plasmid (pTA2, Cat: TAK-101;
Toyobo Co. Ltd., Osaka, Japan) and sequenced using the
M13 forward and reverse primers. The genomic
sequences of the 5’ terminal region of HEV ORF1 were
compared using Bio Edit (version 7.0.9.0) (http://www.
mbio.ncsu.edu/BioEdit/bioedit.html).
Virus isolation from wild Norway rats
To isolate infectious rat HEVs, both the spleens and
intestines of 3 of the HEV-positive wild rats (#38, #49,
#50) were homogenized, filtered through a 0.22-μm
Millipore filter (Millipore, MA), and inoculated into
A549 cells (human alveolar basal epithelial cells), which
are sensitive to HEV infection [38-40]. After adsorption
for 60 min, the cells were washed with PBS and cultured
in DMEM (Sigma-Aldrich Corp., St. Louis, MO) con-
taining 2% fetal bovine serum and insulin-transferrin-
selenium-X supplement (Cat. 51500-056; Life Technolo-
gies Corp., Carlsbad, CA) at 37°C in a 5% CO2 incubator
[40]. The cells were passaged 3 days post-infection (dpi)
and cultured in the same medium conditions. At 7 dpi,
viral RNA was extracted from culture supernatants and
cells by using a QIAamp Viral RNA Mini Kit (Qiagen).
HEV RNA was examined by semi-nested RT-PCR for
the ORF1 region as described above.
Immunofluorescence assay
HEV antigen was detected by immunofluorescence assay
to confirm the infectivity of rat HEV. Virus-infected
cells (7 dpi) fixed with acetone-methanol for 5 min were
washed with PBS and reacted with pig anti-HEV poly-
clonal antibody purified from pigs infected with HEV
genotype 3 [41]. After incubation for 60 min at room
temperature, the cells were washed with PBS containing
0.1% Tween 20 and reacted with FITC-rabbit anti-por-
cine IgG (Zymed) for 60 min at room temperature.
After washing with the buffer, stained cells were exam-
ined under a Zeiss Pascal confocal microscope (LSM 5;
Carl Zeiss AG, Oberkochen, Germany).
Results
We captured 56 wild Norway rats at 6 different loca-
tions around a pig farm where HEV was detected
among the pigs. Anti-HEV-specific antibodies in wild
rats were examined by ELISA; 16 of the 56 (28.6%)
rats were seropositive. HEV RNA ORF1 was detected
in 10 of the 56 rats by semi-nested RT-PCR (17.9%): 5
in the spleen, 5 in the intestines, and 1 (rat ID #49) in
both. HEV RNA at the ORF2 region was also detected
in all of the HEV-RNA (ORF1)-positive samples. Six of
the 10 RT-PCR-positive rats were seropositive in
ELISA (Table 1). To confirm the specificity of the RT-
PCR reaction, PCR products were purified and
sequenced. These PCR products were obtained from
tissues samples of rats captured at different locations,
3 spleens (#36, #38, and #49) and 4 intestines (#27,
#43, #49, and #50). The nucleotide sequences of the
partial ORF1 region of rat and swine HEV were closely
related (swJB-M8, DDBJ: AB481228). Swine HEV geno-
type 3 (swJB-M8) was isolated from pigs in the same
farm where rat HEV was isolated [42]. All 7 nucleotide
sequences from the rats were similar and exhibited the
greatest similarity to HEV genotype 3 (swJB-M8, 95.2-
100%) followed by genotype 1 (81.8-88.6%), genotype 4
(77.2-84.1%), rabbit HEV-like virus (79.5%), genotype 2
Kanai et al. BMC Research Notes 2012, 5:4
http://www.biomedcentral.com/1756-0500/5/4
Page 3 of 6(77.3%), avian HEV-like virus (68.2-70.5%), and rat
HEV-like virus (56.8%).
To examine if the wild rats were carrying infectious
HEV, we infected A549 cells with both splenic and
intestinal homogenates from 3 HEV-positive rats (#38,
#49, and #50). Although no apparent cytopathic effects
were observed in A549 cells after inoculation, HEV
RNA was detected in all samples by RT-PCR from both
the supernatants and cells at 7 dpi. The presence of
HEV antigen in the A549 cells was confirmed by immu-
nofluorescence assay by using pig anti-HEV polyclonal
antibodies (Table 1 and Figure 1).
Discussion
More than 40% of all rats from different regions of the
United States are reported to be seropositive for HEV
[43]. Rats may be infected with HEV after coming in
contact with infected domestic animals or contaminated
sewage. Epidemiological studies indicate that HEV infec-
tion in pigs is ubiquitous and that most pigs older than
3 months are seropositive [44-46]. Although HEV shed-
ding in feces is observed in pigs of all ages, it is more
frequently observed in 2- to 4-month-old pigs than in
slaughter-age (6-month-old) or adult pigs [23,47-50]. In
this study, we found several rat nests around the farm;
the rats also often moved through the pig pens. There-
fore, rats can easily infect HEV by coming in contact
with contaminants.
There are many studies on the presence of an anti-
H E V - s p e c i f i ca n t i b o d yi nw i l d rodents, including the
reports on the detection of an HEV-like virus from Nor-
way rats in Germany [20,51]. In this study, the partial
sequence of HEV from rats was closely related to the
swine HEV genotype 3 (swJB-M8). HEV RNA was
detected not only in the intestines but also in the
spleens of these rats, suggesting that HEV infects and
replicates in wild rats. In this study, HEV RNA was not
detected in liver samples. It is possible that RNA was
rapidly degraded postmortem in this tissue. In addition,
it is possible that only a small quantity of HEV was pre-
sent in the samples.
Norway rats live, to great extent, in close association
with humans. Although the dynamics of HEV in wild
rats is unclear, there is a concern of the possibility of
HEV spreading from rats to other species, including
humans. Pigs are considered as the most important car-
rier of HEV because of the high prevalence of HEV
among domesticated pig populations [36,44,45,48,50].
The fact that infectious HEV is found in pig manure
[52] also emphasizes the importance of controlling HEV
infection among pigs.
The risk factors for HEV infection are related to poor
sanitation in endemic regions as well as HEV shedding
in feces and subsequent water or food contamination in
Table 1 Summary of HEV RNA-positive Norway rats
Rat ID Sex Length (cm) HEV-RNA ELISA OD450 Virus Isolation
Liver Spleen Intestine
11* ND ND -- + 0.10 NT
27 Male 15 -- + 0.33 NT
36 Male 15 -+ - 0.17 NT
38 Female 20 -+ - 0.38 +
40 Male 20 -+ - 0.30 NT
43 Female 15 -- + 0.30 NT
49 Male 19 -+ + 0.39 +**
50 Male 18 -- + 0.68 +
51 Male 15 -- + 0.60 NT
53 Male 19 -+ - 0.49 NT
* ND: the rat could not be measured because of sample damage
** HEV was isolated from both the spleen and intestines. NT: not examined
Figure 1 Detection of HEV-infected cells by
immunofluorescence assay. a A549 cells of uninfected negative
controls. b HEV-specific antigens were detected in A549 cells
infected with splenic homogenate from rat #38.
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human habitats are adjacent; therefore, wild rats fre-
quently enter and leave areas of human habitation. In
this study, rats carried swine HEV and the HEV from
rats was infectious to human A549 cells. The transmis-
s i o no fH E Vf r o mp i g st oh u m a n sh a sb e e nd e m o n -
strated via the consumption of undercooked or
uncooked meat. Therefore, high hygienic standards in
human habitats and in pig farms are an important issue
to prevent the transmission of HEV, and rodent control
may be a critical aspect to address the issue.
Conclusions
In this study, 10 of the 56 (17.9%) rats captured around
a pig farm were positive for HEV genotype 3, and they
were carrying infectious viruses. The contamination risk
of HEV via rats needs to be studied in further detail.
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